Device Tax Repeal Tops AdvaMed Priority List For Fiscal-Cliff Bill
This article was originally published in The Gray Sheet
Executive Summary
The post-election, “lame-duck” Congress will face the prospect of letting massive federal spending cuts take effect and multiple tax increases kick in if it does not take action. Device firms hope to leverage the situation to repeal the looming medical device excise tax and make FDA user-fee fixes while avoiding more Medicare provider cuts.
You may also be interested in...
Budget Accord Should Increase FDA Funding, Free Up User Fees
The deal, which sets total FY 2014 discretionary spending at $1.012 trillion, leaves specific appropriations up to congressional committees and frees up user fees from sequestration for two years, both positive developments for FDA’s financial health. Device groups also tout a non-binding provision to repeal the device tax.
Not-So-Happy New Year: Device Tax Not Addressed In Fiscal Cliff Law
There’s no mention of a device tax delay or repeal in the measure signed by President Obama Jan. 2, and the new law contains some Medicare payment cuts as one-year “Doc Fix” pay-fors.
Not-So-Happy New Year: Device Tax Not Addressed In Fiscal Cliff Law
There’s no mention of a device tax delay or repeal in the measure signed by President Obama Jan. 2, and the new law contains some Medicare payment cuts as one-year “Doc Fix” pay-fors.